A drug consortium in Paraná: analysis of coverage and costsPublic administrators are always concerned in reducing the costs of drugpurchases

• Autor(a) principal: Ferraes, Alide Marina Biehl
• Data de Publicação: 2007
• Outros Autores: Junior, Luiz Cordoni
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista de Administração Pública
• Texto Completo: https://periodicos.fgv.br/rap/article/view/6595
• topic: management strategy; public health service coverage; drugcosts; shared purchases; pharmacoeconomics; drug consortium.; estratégia de gestão; cobertura de serviços públicosde saúde; custos de medicamentos; compras compartilhadas; economiafarmacêutica; consórcio de medicamentos.

This article analyzes the coverage and costs of the Paraná HealthConsortium (CPS) which was created to purchase drugs for municipalitiesof the state of Paraná, Brazil. Coverage included the participatingmunicipalities and their populations. The costs of the acquired drugs werecompared to the values available in the Price Database of the HealthDepartment (BP/MS). Until the end of 2000, the CPS had covered 88.2%of the municipalities and 55.6% of the Paraná population. Among theparticipating municipalities, 83.5% had fewer than 20,000 inhabitants. Theprices of 55 items available on the purchase list of the CPS and in the BP/MS were compared: 46 were lower, one was the same and eight were higherthan those of the BP/MS. Acquisition by the consortium has cost R$332,397.70 (29.7%) less than that by the BP/MS standards. Theimplementation of the CPS was found to be a good administrative strategyof pharmacoeconomics which led to agility and rationality in the use offinancial resources, allowing wider access of the population to drugs.